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Objective: The authors aimed to characterize distinct trajectories of knee pain in adults who had, or were
at high risk of, knee osteoarthritis using data from two population-based cohorts.
Method: Latent class growth analysis was applied to measures of knee pain severity on activity obtained
at 18-month intervals for up to 6 years between 2002 and 2009 from symptomatic participants aged over
50 years in the Knee Clinical Assessment Study (CAS-K) in the United Kingdom. The optimum latent class
growth model from CAS-K was then tested for reproducibility in a matched sample of participants from
the Osteoarthritis Initiative (OAI) in the United States.
Results: A 5-class linear model produced interpretable trajectories in CAS-K with reasonable goodness of
ﬁt and which were labelled “Mild, non-progressive” (N ¼ 201, 35%), “Progressive” (N ¼ 162, 28%),
“Moderate” (N ¼ 124, 22%) “Improving” (N ¼ 68, 12%), and “Severe, non-improving” (N ¼ 15, 3%). We
were able to reproduce “Mild, non-progressive”, “Moderate”, and “Severe, non-improving” classes in the
matched sample of participants from the OAI, however, absence of a “Progressive” class and instability of
the “Improving” classes in the OAI was observed.
Conclusions: Our ﬁndings strengthen the grounds for moving beyond a simple stereotype of osteoar-
thritis as “slowly progressive”. Mild, non-progressive or improving symptom trajectories, although
difﬁcult to reproduce, can nevertheless represent a genuinely favourable prognosis for a sizeable
minority.
© 2014 The Authors. Published by Elsevier Ltd and Osteoarthritis Research Society International. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.
0/).Introduction
Knee osteoarthritis can be considered from two perspectives:
structural damage, and pain and functional limitation1. The two
perspectives are linked but do not match up one-to-one in indi-
vidual patients, either cross-sectionally or over time1. Regardless ofn information criterion; AIC,
n criterion; B-LRT, Bootstrap
nt study; OAI, osteoarthritis
lihood ratio test; WOMAC,
itis Index.
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r Ltd and Osteoarthritis Research Sthis, the popular image of knee osteoarthritis is of a slowly but
inexorably progressive, “degenerative” condition ending in the
need for total joint arthroplasty. Indeed, when viewed as a single
population, the ‘average prognosis’ of symptomatic knee osteoar-
thritis is characterised by small annual losses in joint space nar-
rowing2 and a generally unfavourable long-term course of self-
reported pain and disability3. Yet recent longitudinal studies have
reported high inter-individual differences in the course of osteo-
arthritis structural progression, symptoms, and functional limi-
tation4e8 raising the possibility of an alternative view of the
condition: that it comprises an uncertain number of groups with
distinct long-term trajectories, not all of which may be progressive.
This is plausible given a range of potential underlying phenotypes
including clinically documented aggressive forms of osteoar-
thritis9,10, a realisation that structural disease progression may be
averted through slow but successful repair, at least in earlyociety International. This is an open access article under the CC BY-NC-ND license
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behavioural adjustment to chronic pain13,14.
Six separate studies of prevalent cases of arthralgia or osteoar-
thritis of the hip15,16, knee17,18,20 or mixed hip and knee19 have used
either two-step cluster analysis19 or latent class growth mod-
elling15e18,20 to ﬁt trajectory groups to repeated measures of
pain15,16,20, disability18e20 or joint space width17, over periods of
observation ranging from two15,17 to six19,20 years. Diverse ﬁndings
are normally to be expected from such methods, but this has been
particularly evident due to the heterogeneous design of these
studies. While being mindful of Nagin & Odgers'21 caution against
the “quixotic quest to identify the true number of groups”,
attempting to replicate ﬁndings in separate populations is a
cornerstone in other forms of prognosis research22 and in epide-
miologic research more generally23. For the purposes of this paper
we focused on the clinical syndrome of OA, in which use-related
pain is the cardinal feature. Using samples from two cohorts in
the United Kingdom and the United States, we have sought not only
to derive developmental trajectories of pain severity in persons
with, or at high risk of, knee osteoarthritis but also to investigate
the extent to which they could be reproduced in a separate popu-
lationwith careful matching and similar data collection procedures.
Methods
Study population
Self-report, clinical assessment, and plain radiography data from
two prospective cohort studies e the Knee Clinical Assessment
Study (CAS-K) and the Osteoarthritis Initiative (OAI) e were used.
The design and methods of the CAS-K and OAI have been described
in detail elsewhere24e26.
Brieﬂy, CAS-K is a prospective cohort study of knee pain in
adults over the age of 50 years. Between 2002 and 2003 individuals
reporting knee pain in the previous 12 months were identiﬁed via a
postal survey sent to all adults aged 50 years and over registered
with three general practices in North Staffordshire, United
Kingdom. Of 2226 respondents reporting knee pain and consenting
to further contact 819 attended a research clinic at baseline for
more detailed assessment, including plain radiography of the
knees. Participants were followed up by postal survey at 18, 36, 54,
and 72 months (n ¼ 776, 707, 602 and 512 respondents respec-
tively). In addition, 95% of eligible participants at baseline con-
sented to medical record review and all participants were offered
repeat clinical and radiographic assessments at 36 and 72 months.
Full ethical approval was gained prior to participant recruitment
and participant consent was gained for each study stage.
The OAI is a publicly and privately funded prospective longitu-
dinal cohort study of community-based persons aged 45e79 years
with, or at high risk of, developing clinically signiﬁcant knee OA at
baseline, and approved by the Institutional Review Board at the OAI
Coordinating Center, the University of California, San Francisco.
Participants were recruited between 2004 and 2006 via telephone
screen of 17,457 adults following focussed mailings, advertise-
ments, and community presentations (see Web Appendix 1 for
study exclusion criteria). 4796 eligible participants attended an
enrolment visit and were invited to attend yearly follow-up
research clinics for a period of 6-years (n ¼ 4496, 4324, 4270,
4256, 3935, 3823 respectively, with data collected at clinic or by
telephone if clinic attendance was not possible). For the current
analysis, a sample of symptomatic OAI participants was taken to
match those in CAS-K (further details in Statistical analysis). The
data for the OAI cohort are available in the public domain and can
be downloaded from the OAI database, which is available for public
access at http://www.oai.ucsf.edu/. Speciﬁc datasets downloadedfor the current study are listed in Web Appendix 1, available at
http://www.journals.elsevier.com/osteoarthritis-and-cartilage/
Measurements
Severity of knee pain on activity was measured by self-report on
each occasion and in both cohorts using the ﬁve-item Pain subscale
of the Western Ontario and McMaster Universities Arthritis Index
(WOMAC27). We focussed on knee pain severity as our outcome of
interest as it is of importance to patients and we have previously
argued that pain is inherently easier to attribute to the knee than
functional limitation28,29, although bothWOMAC Pain and Function
scores may follow very similar trajectories over time20. The
WOMAC was used to measure knee pain severity as it has been
shown to be a valid and reliable measure of knee pain severity on
activity and is extensively used in other studies30. It asks about
severity of knee pain on activities “in the last 48 h” with response
options “none”, “mild”, “moderate”, “severe” or “extreme” (total
score 0e20). In the OAI the timeframewas amended to “in the last 7
days”. The questions were completed separately for each knee in
the OAI and we took the maximum sub-scale score for the left and
right knee tomake it comparable to the person-levelWOMAC score
in CAS-K.
The following variables, recorded at baseline, were used for
matching: age, sex, WOMAC Pain, WOMAC Function (0e68), body
mass index (BMI) derived from participants' measured height and
weight, and KellgreneLawrence grade (0e4) for tibiofemoral
osteoarthritis in the most affected knee obtained from weight-
bearing, bilateral, posteroanterior projection views on plain radi-
ography using standardised protocols (the most affected knee was
respondent-nominated in CAS-K and was researcher-deﬁned in the
OAI as the knee with the highest WOMAC pain score. For both co-
horts, the most affected knee was selected at random when both
knees were of equal severity).
In CAS-K a self-reported measure of locomotor disability was
used to explore the construct validity of the trajectories extracted
(it was collected at baseline and 6-year follow-up and combines
three questions on walking and two questions on stair climbing
from the SF-36 Physical Functioning subscale31,32. It is scaled
4.906 (less disability) to 5.035 (more disability); converted to 0 to
9.941 for analysis). In addition, the following variables were used in
CAS-K to describe the baseline characteristics of participants in
each of the trajectory groups: area-level index of multiple depri-
vation33, social class34,35, employment status, going on to full time
education after school, general health (measured on a likert scale
from “Excellent” to “Poor”31), anxiety and depression (as measured
by the Hospital Anxiety and Depression Scale e scaled 0e21 for
anxiety and pain respectively36), widespread pain37, pain/aching/
stiffness in the knee in the last month, knee pain severity at the
present time (scaled 0e10), time of onset, severity of tibiofemoral
and patellofemoral joint radiographic OA38 and a prognostic score
based on original work by Von Korff and Miglioretti (2005)39 and
previously applied to the CAS-K cohort40.
In both CAS-K and OAI the receipt of total knee arthroplasty
during the follow-up period was identiﬁed through a combination
of medical record review, study radiographs taken at follow-up
visits, and self-reports from each follow-up questionnaire. Self-
reported treatment data were also collected in both cohorts to
indicate treatments used at baseline and in the month preceding
each follow-up visit (CAS-K: knee-speciﬁc treatments used for any
duration; OAI: arthritis or joint pain treatments used for more than
half the days in the last month). Any health care consultations for
knee pain were also recorded in CAS-K over the 6-year follow-up
period with general practitioner (GP) consultations measured by
medical record review and physiotherapist/hospital specialist
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collection point of “since your baseline assessment”.
Statistical analysis
Our analysis was conducted in four steps: identiﬁcation of
distinct, interpretable trajectories of knee pain severity and
assessment of construct validity of the trajectories within the CAS-
K cohort; selection of a sample of OAI participants matched on key
baseline characteristics to CAS-K participants; attempted repro-
duction of the number and pattern of trajectories observed in CAS-
K within the matched OAI sample; comparison of the baseline
characteristics and description of health care use between different
trajectories within the same cohort and between similar trajec-
tories in CAS-K and OAI. The four steps were completed after
excluding any WOMAC Pain scores collected post total knee
arthroplasty in either knee.
Latent class growth modelling to identify trajectories of knee pain
severity in CASeK participants
Latent class growth analysis is a semi-parametric statistical
technique that aims to model individual trajectories over time us-
ing polynomial curves after accounting for unobserved heteroge-
neity within the population41,42. A search for the optimum latent
class growth model was conducted in CAS-K by ﬁtting a one-class
linear model to the data and then successively increasing the
number of classes until model ﬁt no longer improved. Model ﬁt was
based on statistical criteria (see Web Appendix 2) and on a judge-
ment of model interpretability as recommended by Jung et al.41. We
deﬁned model interpretability in this context to be a model that
showed at least one group with a signiﬁcant change in their knee
pain trajectory over time. We used this deﬁnition to ensure that our
latent class growth model provided more understanding of our
data than could be gained from a random effects model ﬁtted to the
sample as a whole. We were mindful, however, to ensure that
statistical ﬁt was not greatly reduced for this criteria to be satisﬁed.
A series of sensitivity analyses were conducted on CAS-K and OAI to
evaluate the assumption of linear trajectories, and to examine the
impact of excluding the baseline measurement, and varying the
number of non-missing measurement points required for the
participant to be included in the analysis (Web Appendix 3).
To address construct validity, change in locomotor disability
from baseline to 6-year follow-up was described for each trajectory
group from the optimum model in CAS-K. It was hypothesised that
trajectory group membership would be related to change in loco-
motor disability although speciﬁc hypotheses around the nature of
this relationship were not stated until the number and form of the
trajectory groups were known.
Selection of a matched sample of OAI participants
Propensity score matching43 was used to obtain a sample of OAI
participants matched to CAS-K participants on the following
baseline characteristics: age, gender, BMI, WOMAC Pain and
Function scores and KellgreneLawrence score in the tibiofemoral
joint of the patients' most problematic (index) knee. This approach
was taken so that model reproducibility could be tested after
controlling for (as far as possible) any baseline imbalance between
the cohorts (for further details see Web Appendix 4).
Knee pain severity trajectories in OAI participants
A latent class growth model with the optimum number of
classes and polynomial form (as derived from the CAS-K data) was
applied to the matched OAI data. Regression coefﬁcients from the
matched OAI model were compared to those from CAS-K after
regression coefﬁcients had been converted into per-year rates ofchange in WOMAC pain for ease of comparison. Goodness-of-ﬁt
indices (as described in Web Appendix 2) were compared for
models with ~k classes, ~kþ 1 classes, and ~k 1 classes (where ~k is
the optimum number of classes in CAS-K) to see if a model with ~k
classes was indeed optimum for the OAI data.
Descriptive characteristics and health care use
Descriptive statistics were used to compare the baseline char-
acteristics of participants in the derived trajectory groups within
CAS-K andmultinomial logistic regressionwas used to test whether
such differences were statistically signiﬁcant. The rates of health
care use in each cohort were also described using numbers and
percentages.
Results
Study population
A total of 570 CAS-K participants (mean (SD) age: 64 (8.0) years,
54% female) were eligible for inclusion after excluding 16 cases
with an existing diagnosis of inﬂammatory arthritis at baseline, 213
with WOMAC Pain data missing at baseline or available at fewer
than two follow-up points, and 20 missing data on the matching
variables. Participants excluded from the analysis were older, had
more severe knee pain, more functional difﬁculty and greater evi-
dence of tibiofemoral osteoarthritis at baseline than those included
in the analysis (a ﬁnding that could have occurred as inclusion in
the analysis was inﬂuenced by excluding participants'WOMAC data
post total knee arthroplasty) (Web Table 1). We have previously
shown that attendees at the clinical assessment are largely repre-
sentative of the population of older adults with knee pain26.
Identiﬁcation of pain trajectories in CAS-K
A linear 1-class latent class growth model showed an average
increase in WOMAC Pain score of 0.08 points per year over the 6-
year period (95% conﬁdence interval: 0.02, 0.14). A 4-class linear
model improved model ﬁt, but with classes differentiated only by
baseline score and not by slope (intercepts 2.4, 6.0, 10.4 and 15.3
respectively). The 5-class linear model produced interpretable
trajectories and goodness-of-ﬁt statistics that were not greatly
inferior to the 4-class model, and was considered optimal (Table I).
The trajectory groups were labelled on the basis of their intercepts
and slopes as: “Mild, non-progressive” (N¼ 201, 35%), “Progressive”
(N ¼ 162, 28%), “Moderate” (N ¼ 124, 22%) “Improving” (N ¼ 68,
12%), “Severe, non-improving” (N ¼ 15, 3%) (Fig. 1).
In support of construct validity, participants in the “Progressive”
group showed locomotor disability change scores that were
signiﬁcantly different from those in the “Mild, non-progressive”
group i.e., a greater rate of deterioration in the “Progressive” group
when compared to the “Mild, non-progressive” group (Table II). In
contrast, despite change in locomotor disability being greater in the
“Improving” group than in the reference group, this difference was
not statistically signiﬁcant, so evidence of construct validity was
lacking for this comparison.
Reproducibility of pain trajectories in OAI
Amatched sample of 570OAI participantswas drawn froma total
pool of 3315 eligible participants. The characteristics of thematched
OAI data and CAS-K were similar (Table III) and the median and
interquartile range of the propensity score difference was zero.
A 5-class linear latent class growthmodel was applied to the OAI
data and ﬁtted the matched OAI data well (all posterior probabili-
ties >0.7 and entropy ¼ 0.83), with ﬁt indices similar to those
Table I
Goodness-of-ﬁt statistics for linear WOMAC pain models
Classes AIC BIC ABIC Entropy VLMR LRT Adjusted LMR LRT PB LRT Class N Average posterior probability
CAS-K
1 14,682 14,713 14,690 570 1.0
2 13,691 13,734 13,703 0.83 P < 0.001 P < 0.001 P < 0.001 346, 224 0.96, 0.94
3 13,361 13,417 13,376 0.83 P < 0.001 P < 0.001 P < 0.001 215, 120, 235 0.94, 0.94, 0.90
4 13,263 13,333 13,282 0.86 P < 0.001 P < 0.001 P < 0.001 226, 14, 211, 119 0.90, 0.93, 0.94, 0.93
5 13,235 13,318 13,258 0.79 P ¼ 0.206 P ¼ 0.220 P < 0.001 201, 68, 15, 162, 124 0.95, 0.70, 0.95, 0.80, 0.91
6 13,223 13,318 13,249 0.75 P ¼ 0.155 P ¼ 0.165 P ¼ 0.013 46, 126, 14, 81, 109, 194 0.69, 0.72, 0.93, 0.70, 0.91, 0.93
OAI
4 18,059 18,137 18,080 0.86 P ¼ 0.249 P ¼ 0.260 P < 0.001 251, 44, 118, 157 0.95, 0.92, 0.91, 0.87
5 18,004 18,095 18,029 0.83 P ¼ 0.207 P ¼ 0.214 P < 0.001 235, 26, 106, 139, 64 0.94, 0.89, 0.85, 0.83, 0.85
6 17,961 18,065 17,989 0.82 P ¼ 0.037 P ¼ 0.041 P < 0.001 80, 27, 232, 63, 30, 138 0.81, 0.90, 0.94, 0.84, 0.81, 0.81
Abbreviations: AIC, Akaike Information Criteria; ABIC, Sample-size adjusted BIC; BIC, Bayesian Information Criteria; LMR LRT, Lo-Mendell-Rubin likelihood ratio test; PBLRT,
parametric bootstrapped likelihood ratio test; VLMR LRT, Vuong-Lo-Mendell-Rubin likelihood ratio test.
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the existence of “Mild, non-progressive” and “Severe, non-
improving” classes (presenting with similar prevalence to CAS-K).
However, the “Mild, non-progressive” class in the OAI includes
some participants with relatively high baselineWOMAC pain scores
that are then reduced and maintained at a lower level for all sub-
sequent time points (Fig. 1). A “Progressive” subgroup did not
emerge in the OAI data and three subgroups of “Moderate” trajec-
tories were apparent in the OAI data, compared to only one in
CAS-K.
Participant baseline characteristics and health care utilisation
The “Severe, non-improving” group of participants are charac-
terised by having the highest percentage of females, lowest socialFig. 1. WOMAC Pain Scores by Trajectory Group Membership for (A) CAS-K and (B) Match
points; 95% conﬁdence interval in brackets.class, highest levels of anxiety and depression, poorer general
health, worst pain and function, and more evidence of severe
radiographic OA (Table IV). However this group does not have
longer duration of knee problems. All baseline characteristics
showed differences that were statistically signiﬁcant between the
trajectory groups (P < 0.05).
Health care utilisation was higher for the trajectory class rep-
resenting greater pain severity i.e., the “Severe, non-improving”
compared to the “Mild, non-progressive” group in CAS-K and the
OAI (Tables IV and V).
Sensitivity analyses
The choice of the optimum number of classes, the size of the
goodness-of-ﬁt statistics and the resulting class allocation in CAS-Ked OAI Sample (N ¼ 570). Abbreviations: PYRC ¼ Per-year rate of change in WOMAC
Table III
Baseline characteristics of participants in the CAS-K analysis cohort (United
Kingdom (2002e2003)) and the matched OAI sample (United States (2004e2006))
CAS-K (N ¼ 570) OAI (N ¼ 570)
Age (years): mean (SD)* 64 (8.0) 64 (8.5)
Female gender* 309 (54) 296 (52)
BMI: mean (SD)* 29.5 (5.0) 29.4 (4.9)
Time since problemy onset
No knee pain for most days in
a month
143 (25)
<1 year 57 (10) 63 (11)
1e5 years 201 (35) 160 (28)
5þ years 312 (55) 204 (36)
WOMAC function27: median
(IQR)*
17.0 (6.0, 30.0) 18.0 (5.0, 30.0)
KellgreneLawrence score in tibiofemoral joint*
0 308 (54) 298 (52)
1 54 (9) 51 (9.0)
2 82 (14) 96 (17)
3 70 (12) 63 (11)
4 56 (10) 62 (11)
Baseline exclusion criteria in OAI
Bilateral total knee
arthroplasty
0 (0) 0 (0)
Bilateral severe joint space
narrowing
22 (4) 0 (0)
Unilateral total knee
arthroplasty and
contralateral severe joint
space narrowing
0 (0) 0 (0)
Aged 80 years and over 21 (4) 0 (0)
Excessive weight for
magnetic resonance imaging
scanz
10 (2) 0 (0)
WOMAC pain27: median (IQR)
Baseline* 5.0 (2.0, 9.0) 5.0 (2.0, 9.0)
12-months N/A 3.0 (1.0, 7.0)
18-months 5.0 (2.0, 9.0) N/A
24-months N/A 3.0 (1.0, 7.0)
36-months 6.0 (2.0, 10.0) 3.0 (0.0, 7.0)
48-months N/A 3.0 (0.0, 7.0)
54-months 5.0 (2.0, 9.0) N/A
60-months N/A 3.0 (0.0, 7.0)
72-months 6.0 (3.0, 10.0) 3.0 (0.0, 7.0)
Abbreviations: IQR, Inter-quartile range; N/A, Not applicable; SD, standard devia-
tion; WOMAC, Western Ontario & McMaster Universities Osteoarthritis Index.
Numbers are N (%) unless otherwise stated.
* Variable used in matching.
y For CAS-K, onset relates to the current knee problem, for OAI, onset relates to
knee pain, aching or stiffness experienced on most days or more in a month for
either knee.
z Males >130 kg, females >114 kg.
Table II
Change in locomotor disability by trajectory groups in CAS-K
Change in disability
Mild, non-progressive (n ¼ 141) 0
Progressive (n ¼ 119) 0.60 (1.13, 0.07)
Moderate (n ¼ 78) 0.40 (1.00, 0.20)
Improving (n ¼ 44) 0.50 (0.23, 1.24)
Severe, non-improving (n ¼ 10) 0.34 (1.06, 1.73)
Change in disability ¼ Change in locomotor disability (baseline e 6-year follow-up)
i.e., a negative score on the outcome represents a worsening of locomotor disability
over the 6-year follow-up time-period. Figures are regression coefﬁcients and 95%
conﬁdence intervals from an analysis of variance model with change in loco-motor
disability as the dependent variable.
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cubic model was used to model the data (Web Tables 2 and 3) and
all models converged to a global solution. For the CAS-K data, tra-
jectory plots were insensitive to the number of measurement
points with complete WOMAC Pain data. However when the
baseline measurement was excluded from the analysis only the
“Mild, non-progressive”, “Moderate” and “Severe, non-improving”
groups were replicated (Web Figs. 1e3).
The sensitivity analyses of the OAI data revealed some model
instability for the 5-class linear model when criteria for the number
of non-missing WOMAC scores required for analysis were varied,
however all models supported the presence of “Mild, non-pro-
gressive”, “Severe, non-improving” classes and the absence of a
“Progressive” class (Web Figs. 1 and 2). The model was relatively
stable when baseline data were omitted from the analysis (Web
Fig. 3).
Discussion
Osteoarthritis is a common, often disabling, chronic condition of
importance to the health of the public and health services world-
wide44,45. Discovering reproducible pain trajectory groups is of
potential conceptual and practical signiﬁcance for translation into
clinical medicine to inform more personalised advice on prognosis,
efﬁcient targeting of treatment, and intensity of monitoring. Our
study ﬁndings corroborate some previous observations on
distinctive pain and functional limitation trajectories in knee
osteoarthritis while providing several new insights. Our focus has
been on the clinical syndrome of pain and functional limitation
which is associated with but not coterminous with radiographically
deﬁned structural knee OA.
The dominant picture that emerges from data in both cohorts in
this study and in previous studies of osteoarthritis15,16,18e20,46 and
other common musculoskeletal pains in adulthood47 is that of
trajectories of pain severity and self-reported functional limitation
which, in the context of existing clinical care and self-management,
are often non-progressive over several years. Although not directly
observable in the present data, ﬂuctuations and exacerbations are
likely to be super-imposed on these underlying trajectories5,46,48,49.
In the open population a large group is characterised by mild, non-
progressive pain equivalent to the ﬁftieth centile in normative data
from adults of the same age in the general population50. Given the
favourable prognosis, preventing unnecessary costs and harms
associated with over-diagnosis and over-management are likely to
be important considerations. At the other extreme, a small number
of individuals in both UK and US cohorts were assigned to a tra-
jectory group we labelled “severe, non-improving” and that was
characterised by high health care utilisation and persistently severe
pain exceeding levels typically seen in cases recommended for joint
arthroplasty51. The demographic characteristics and absence of
joint arthroplasty in the OAI sample members of this trajectorygroup, however, argue against a simple interpretation of severe
end-stage osteoarthritis and further characterisation is needed.
In CAS-K, when all data time-points were analysed one class was
extracted that showed an improvement in pain severity over time
with this pattern accounting for 11e20%. Symptom improvement in
osteoarthritis is plausible14,52 and has been observed in some
previous studies19,53,54. The extraction of an ‘improver’ group was,
however, highly sensitive in the OAI data to the number of
completed measurement points required for inclusion in the
analysis. Differences between the two cohorts in the timing of
enrolment in relation to symptom ﬂuctuation may be responsible
but it serves to highlight the wider challenge of beginning obser-
vations in prevalent cases with time-varying symptoms.
A concern is that symptom improvement may nevertheless be
accompanied by signiﬁcant functional deterioration, due for
example to progressive avoidance of activities associated with
actual or anticipated pain53,55,56. Our data do not support this
concern. We found no evidence over the 6-year period among CAS-
K improvers of either worsening self-reported locomotor disability
Table IV
Baseline characteristics and health care use over the 6-year follow-up period for CAS-K (N ¼ 570)
Characteristic Mild, non-progressive
N ¼ 201
Progressive
N ¼ 162
Moderate
N ¼ 124
Improving
N ¼ 68
Severe, non-improving
N ¼ 15
Baseline characteristics
Age* 63 (8.1) 65 (7.4) 66 (8.4) 64 (8.5) 64 (6.7)
Female gender 108 (54) 94 (58) 70 (56) 25 (37) 12 (80)
BMI* 27.7 (4.2) 29.5 (4.5) 31.7 (5.6) 30.1 (5.0) 31.6 (5.5)
Index of multiple deprivation33,* 14,497 (8138) 12,112 (7430) 11,063 (7414) 12,514 (7601) 9083 (4870)
Manual occupation34,35 81 (45) 91 (61) 74 (69) 36 (62) 11 (79)
Currently employed 65 (34) 37 (23) 14 (12) 14 (21) 0 (0)
Went on to full time education after school 49 (25) 13 (8) 11 (9) 9 (14) 0 (0)
Overall general health
Excellent 16 (8) 0 (0) 1 (1) 2 (3) 0 (0)
Very good 56 (28) 23 (14) 9 (7) 10 (15) 0 (0)
Good 97 (49) 94 (59) 37 (30) 30 (44) 3 (20)
Fair 28 (14) 37 (23) 60 (49) 19 (28) 10 (67)
Poor 2 (1) 6(4) 16 (13) 7 (10) 2 (13)
HADS e anxiety36,* 5.4 (3.4) 6.8 (4.0) 8.1 (4.1) 6.7 (5.0) 9.3 (2.0)
HADS e depression36,y 2.0 (1.0, 4.0) 4.0 (2.0, 6.0) 6.0 (4.0, 9.0) 4.0 (2.0, 7.0) 7.0 (6.0, 11.0)
Widespread pain37 21 (10) 36 (22) 49 (40) 15 (22) 8 (53)
Locomotor disability score31,32,* 2.2 (1.8) 4.0 (2.2) 6.3 (2.6) 4.3 (2.9) 7.9 (1.2)
Pain, aching or stiffness in the knee in the last month
No days 32 (16) 6 (4) 1 (1) 1 (1) 0 (0)
Few days 79 (39) 41 (25) 8 (6) 12 (18) 0 (0)
Some days 58 (29) 51 (31) 24 (19) 21 (31) 1 (7)
Most days 28 (14) 46 (28) 54 (44) 27 (40) 5 (33)
All days 4 (2) 18 (11) 37 (30) 7 (10) 9 (60)
Knee pain severity at the present timey 1.0 (0.0, 2.0) 3.0 (1.0, 4.0) 5.0 (4.0, 7.0) 3.0 (1.0, 5.0) 8.0 (7.0, 8.0)
WOMAC function27,y 5.0 (1.0, 10.0) 17.5 (10.0, 23.0) 35.0 (29.9, 41.0) 25.0 (18.5, 34.0) 50.0 (44.0, 55.0)
Onset of knee problem
<1 year 33 (16) 12 (7) 2 (2) 9 (13) 1 (7)
1-year to 5-years 70 (35) 67 (41) 36 (29) 21 (31) 7 (47)
5-years or more 98 (49) 83 (51) 86 (69) 38 (56) 7 (47)
Severity of tibiofemoral joint radiographic OA38
No deﬁnite radiographic OA 135 (67) 85 (52) 61 (49) 43 (63) 5 (33)
Mild radiographic OA 42 (21) 29 (18) 21 (17) 11 (16) 4 (27)
Moderate/severe radiographic OA 24 (12) 48 (30) 42 (34) 14 (21) 6 (40)
Severity of patellofemoral joint radiographic OA38
No deﬁnite radiographic OA 103 (51) 51 (31) 32 (26) 21 (31) 2 (13)
Mild radiographic OA 71 (35) 73 (45) 57 (46) 34 (50) 6 (40)
Moderate/severe radiographic OA 27 (13) 38 (23) 35 (28) 13 (19) 7 (47)
Chronic pain risk score39,y 5.0 (3.5, 8.0) 10.0 (7.0, 13.0) 17.0 (11.0, 21.0) 11.0 (8.0, 14.0) 22.5 (21.0, 23.0)
Health care use
Total knee arthroplasty received during
6-yr follow-up period
2 (1) 4 (2) 8 (6) 1 (1) 3 (20)
Averagez treatment use prevalence over
the ﬁve study time points (%)
Paracetamol 15% 44% 42% 28% 36%
NSAIDSx 16% 30% 36% 24% 31%
Other analgesiak 10% 36% 55% 20% 73%
Creams, gels or rubs 15% 40% 49% 28% 73%
Exercise for knee pain 8% 16% 25% 13% 36%
Dieting to lose weight 14% 28% 35% 30% 46%
Treatment or consultation received at any point
during the 6-yr follow-up period
Knee injection¶ 6 (4) 10 (9) 16 (20) 1 (2) 5 (45)
Physiotherapist 28 (20) 45 (38) 43 (49) 14 (31) 8 (62)
Hospital specialist 17 (12) 31 (26) 47 (52) 13 (28) 7 (58)
GP# 65 (34) 100 (63) 80 (71) 29 (45) 12 (80)
Abbreviations: HADS, Hospital Anxiety and Depression Scale. Figures are numbers and percentages unless otherwise stated. For statistical testing, categorisation of the
following variables was used due to small sample sizes: General health: Excellent/Very Good/Good vs Fair/Poor, Knee pain in the last month: Most days or more vs some days
or less, and Onset of knee problem: <1 year vs >1 year.
* Mean (standard deviation).
y Median (interquartile range).
z Average treatment prevalence is a weighted mean with wi ¼ Ni=P5i¼1Ni and AP ¼
P5
i¼1wi pi where w ¼ weight, i ¼ time point, N ¼ number of participants without
missing data, AP ¼ average prevalence and p ¼ prevalence of treatment use.
x Includes ibuprofen, aspirin, diclofenac, naproxen and COX-II.
k Includes co-proxamol, co-codamol and dihydrocodeine.
¶ Knee injection data was collected at each visit using a time frame of “since your baseline assessment” so an average prevalence could not be calculated.
# Denominator includes only participants giving consent to medical record review N ¼ 543.
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Table V
Health care use over the 6-year follow-up period for the matched OAI sample (N ¼ 570)
Characteristic Mild, non-progressive
N ¼ 235
Moderate (A)
(intercept ¼ 4.8)
N ¼ 139
Moderate (B)
(intercept ¼ 6.9)
N ¼ 106
Moderate (C)
(intercept ¼ 9.9)
N ¼ 64
Severe, non-improving
N ¼ 26
Age* 64 (8.5) 64 (8.3) 64 (8.6) 64 (9.0) 59 (6.9)
Female gender N (%) 111 (47) 65 (47) 61 (58) 39 (61) 20 (77)
Knee function
Baseline WOMAC function27,y 4.0 (0.0, 13.0) 20.0 (12.0, 26.0) 25.3 (19.0, 34.0) 35.5 (29.4, 41.0) 41.7 (37.0, 48.9)
Health care use
Total knee arthroplasty received
during 6-yr follow-up period
1 (0) 6 (4) 12 (11) 5 (8) 1 (4)
Averagez treatment use prevalence
over the seven study time points (%)
Paracetamol (Tylenol, acetaminophen) 6% 12% 19% 25% 29%
NSAIDS 18% 30% 31% 35% 53%
COXIBS (e.g., Bextra, Celebrex) 2% 5% 7% 5% 6%
Strong prescription pain
medication (e.g., Narcotics)
2% 4% 7% 12% 14%
Figures are numbers and percentages unless otherwise stated.
* Mean (standard deviation).
y Median (interquartile range).
z Average treatment prevalence is a weighted mean with wi ¼ Ni=P7i¼1Ni and AP ¼
P7
i¼1wi pi where w ¼ weight, i ¼ time point, N ¼ number of participants without
missing data, AP ¼ average prevalence and p ¼ prevalence of treatment use.
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measurements of knee ﬂexion range of movement (data not
shown).
Conversely, irrespective of the number of measurement points
with WOMAC pain data, a ‘progressive’ group was found in every
analysis of CAS-K (except when baseline was removed from the
analysis) and in no analyses of OAI, a ﬁnding unlikely to be solely
explained by selective loss to follow-up in the OAI as follow-up
rates are generally high. In general, there appeared to be a more
favourable prognosis in the US-based OAI cohort than in the UK-
based CAS-K cohort, consistent with previous cross-sectional
comparisons of clinical severity between OAI and other cohorts57.
A number of limitations in the current study should be high-
lighted. A maximum of seven measurements with minimum in-
terval of 12 months would be expected to limit the ability to detect
rapid resolution or deterioration and to selectively promote the
identiﬁcation of trajectories that do not ﬂuctuate greatly over time.
Six years is an insufﬁciently long period of observation to
completely rule out progression and our ﬁndings must be inter-
preted in the context of that time-frame. The small sample size in
the “Severe, non-improving” group, although replicated in all of our
sensitivity analyses, limits the ability we have to explore which
combination of participant characteristics best predict trajectory
group membership so our observations about between-group dif-
ferences are interpreted without adjustment for any of the addi-
tional participant characteristics observed.
We also note that some of our comparisons are limited by the
different data collection methods used in each cohort, with a
particular limitation being that we have assumed that the person-
speciﬁc WOMAC knee pain scores in CAS-K are equivalent to the
maximum of the side-speciﬁc WOMAC measures in the OAI, and
that our ﬁndings on health care use should be viewed in the context
of differing health care systems in the UK and US (e.g., access to
treatment and services). In addition, we have not explored the
more detailed issues around healthcare use such as participant's
willingness to accept, use and adhere to the treatments offered that
could affect participant's symptom trajectories over time. We also
note that as the OAI and CAS-K cohorts are not inception cohorts for
this analysis, the baseline data reﬂects the broad range of OA
radiographic and clinical severities that could present to health care
services at any one point in time. We have also limited our com-
parisons of trajectory shape between cohorts to be descriptive,rather than statistical, as it would be inﬂuenced by the sample sizes
obtained in the trajectory groups compared. Additionally, as
matching was used to test for model reproducibility our results
only apply to participants with baseline characteristics similar to
those in CAS-K rather than to participants in cohorts where
differing baseline inclusion criteria apply.
Finally our study was about clinical OA and not radiographic
severity. The concern may be that those with no deﬁnite radio-
graphic OA at baseline dominate those who have a favourable
clinical course. However Table IV illustrates that stratiﬁcation by
radiographic grade at baseline does not neatly separate those who
subsequently have favourable and unfavourable pain trajectories
over time.
Overall, however, our ﬁndings strengthen the empirical basis for
moving beyond the general characterisation of osteoarthritis as
“slowly progressive”. Indeed the observation of mild, non-
progressive or improving symptom trajectories, which appear to
be more than an artefact or simply the outcome of activity avoid-
ance or high levels of treatment, directly challenges this negative
stereotype. For a sizeable minority of individuals, including those
with deﬁnite radiographic evidence of osteoarthritis which is now
regarded as being relatively ‘late’ in the disease process, pain has a
favourable prognosis in the medium-to long-term.
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